Patents by Inventor Philippe Arzel

Philippe Arzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
    Publication number: 20240336602
    Abstract: The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.
    Type: Application
    Filed: May 12, 2024
    Publication date: October 10, 2024
    Inventors: Sara ALLASIA, Philippe ARZEL, Patrick CHALTIN, Amuri KILONDA, Arnaud MARCHAND, Jean-Christophe VANHERCK, Thomas VOETS, Joris VRIENS, Melanie REICH, André WELBERS
  • HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
    Publication number: 20240051949
    Abstract: The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.
    Type: Application
    Filed: November 24, 2021
    Publication date: February 15, 2024
    Inventors: Sara ALLASIA, Philippe ARZEL, Patrick CHALTIN, Amuri KILONDA, Arnaud MARCHAND, Thomas VANHERCK, Thomas VOETS, Joris VRIENS, Melanie REICH, André WELBERS
  • ARYL DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
    Publication number: 20230391739
    Abstract: The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.
    Type: Application
    Filed: November 4, 2021
    Publication date: December 7, 2023
    Inventors: Sara ALLASIA, Philippe ARZEL, Patrick CHALTIN, Amuri KILONDA, Arnaud MARCHAND, Thomas VANHERCK, Thomas VOETS, Joris VRIENS, Melanie REICH, André WELBERS
  • Kinase Inhibitors
    Publication number: 20090233960
    Abstract: The present invention relates to new AGC kinase inhibitors, in particular to compounds of Formula I, II, or III or a stereoisomer, tautomer, racemic, metabolite, pro- or predrug, salt, hydrate, or solvate thereof, I II III wherein X, R1, R2, R3, R31, n, and m have the meaning defined in the claims. In particular, the present invention relates more specifically to ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease.
    Type: Application
    Filed: October 13, 2006
    Publication date: September 17, 2009
    Applicant: Devgen NV
    Inventors: Philippe Van Rompaey, Philippe Arzel, Olivier Raynald Defert, Dirk Casimir Maria Leysen
  • Kinase inhibitors
    Publication number: 20070191420
    Abstract: The invention provides the use of a compound or a composition comprising said compound for inhibiting the activity of at least one kinase, other than ROCK kinase, in vitro or in vivo, pharmaceutical and/or veterinary compositions comprising such compounds, medical and veterinary uses of such compounds and the compounds themselves.
    Type: Application
    Filed: February 18, 2005
    Publication date: August 16, 2007
    Inventors: Dirk Leysen, Olivier Defert, Jan Octaaf De Kerpel, Eric Pierre Fourmaintraux, Philippe Arzel, Gert Jules De Wilde